Compound information
- Natural Products
- ZC130154
- Molecular Formula
- C13H16N2O3S
- Molecular Weight
- 280.088163372 g/mol
- Structure
-
- IUPAC Name
- N-[(3S)-1-(benzenesulfonyl)pyrrolidin-3-yl]prop-2-enamide
- InChI
- InChI=1S/C13H16N2O3S/c1-2-13(16)14-11-8-9-15(10-11)19(17,18)12-6-4-3-5-7-12/h2-7,11H,1,8-10H2,(H,14,16)/t11-/m0/s1
- InChI Key
- KZMWCKGBKPBJFV-NSHDSACASA-N
- SMILES
- C=CC(=O)N[C@H]1CCN(S(=O)(=O)c2ccccc2)C1
- Source
- ZINC001875367358
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 19 | Ring Count | 2 |
Heteroatom Count | 6 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 66.48 Å2 | LogP | 0.891 |
LogS | -2.433 | LogD | 1.158 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.004 | Pgp substrate | 0.978 |
HIA | 0.967 | F20 % | 0.995 |
F30 % | 0.823 | Caco-2 | -4.804 |
MDCK | -4.711 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.26 | PPB | 79.676 |
VD | 0.548 | Fu | 0.799 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.005 | CYP1A2 substrate | 0.434 |
CYP2A6 substrate | 0.633 | CYP2B6 substrate | 0.639 |
CYP2C19 inhibitor | 0.075 | CYP2C19 substrate | 0.831 |
CYP2C8 substrate | 0.672 | CYP2C9 inhibitor | 0.007 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.003 |
CYP2D6 substrate | 0.954 | CYP2E1 substrate | 0.777 |
CYP3A4 inhibitor | 0.015 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.358 | CL | 5.532 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.01 | Hepatotoxicity | 0.91 |
Mutagenicity | 0.002 | Rat Oral Acute Toxicity | 0.255 |
FDAMDD | 0.697 | Skin Sensitization | 0.046 |
Carcinogenicity | 0.406 | Eye Corrosion | 0.509 |
Eye Irritation | 0.893 | Respiratory Toxicity | 0.56 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.296 | IGC50 | 2.924 |
LC50FM | 1.971 | LC50DM | 3.102 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.19 | NR-AR-LBD | 0.31 |
NR-AhR | 0.006 | NR-Aromatase | 0.032 |
NR-ER | 0.233 | NR-ER-LBD | 0.31 |
NR-PPAR-gamma | 0.204 | SR-ARE | 0.829 |
SR-ATAD5 | 0.33 | SR-HSE | 0.07 |
SR-MMP | 0.013 | SR-p53 | 0.024 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.